2023 Autumn Conference Posters

Click title to view pdf. Posters are listed in alphabetical order by first author.

Development and content validation of a seizure eDiary optimized for clinical trials: A partnership with industry epilepsy experts (Abstract)

Brady

Optimizing automated objective speech technologies for measuring negative symptoms (Abstract)

Cohen

The effects of digital neuromodulation: Basket design clinical trial for signal detection (Abstract)

Colbert

Evolution of digital therapeutics: Utilizing clinical trials, reverse translation, and in silico methods for enhanced product lifecycle management (Abstract)

Dahlem

The utility of enhanced data surveillance on the presence of data quality concerns in acute schizophrenia clinical trials. A post hoc analysis (Abstract)

Daniel

The IMPACT study: A randomized placebo-controlled trial using an N-of-1 design (Abstract)

Davis

Effects of repeated intravenous esketamine administration on affective biases (Abstract)

Dawson

A semantic scale analysis of instruments intended to evaluate psychedelic experience in clinical trials (Abstract)

Di Cesare

Psilocybin therapy for treatment resistant depression: Prediction of clinical outcome by natural language processing (Abstract)

Dougherty

Automated assessment of PANSS interview quality (Abstract)

Efstathiadis

Eligibility review using the Mini International Neuropsychiatric Interview for inpatient schizophrenia trials: Usability & common issues (Abstract)

Engler

Words (and pronouns) matter: Increasing LGBTQIA+ representation and visibility in MDD clinical trials (Abstract)

Evans

Use of digital health technology tool to assess medication adherence in schizophrenia: The INTERACT study experience (Abstract)

Fan

Mitigating inferential errors in external control data for rare genetic conditions affecting neurodevelopment (Abstract)

Farmer

Novel genetic in-vitro diagnostic test to predict efficacy of BH-200, a V1b antagonist, in major depressive disorder: a phase II randomized controlled trial (Abstract)

Gehrlach

Utilizing AI on data from anxiety and schizophrenia trials to identify causal clusters of variables for drug & placebo response (Abstract)

Geraci

A Phase 2 multi-center randomized double-blind parallel-group dose-finding study to assess effect of four doses of MM-120 for anxiety (Abstract)

Karas

Validating linguistic feature extraction across multiple languages using open source NLP tools (Abstract)

Kindellan

Objective measures of psychiatric symptoms through speech and visual features during clinical interaction (Abstract)

König

Differentiating primary and secondary expressive negative symptoms for remote digital trials using a multimodal dialogue platform (Abstract)

Kothare

Does the relationship between the BNSS and the PANSS negative factor score differ between negative symptom and acute exacerbation schizophrenia studies? (Abstract)

Kott

Screening Mini Mental State Examination assessment duration as a marker of possible score inflation (Abstract)

Kott

Machine learning-supported ERP-based biomarker identification in MCI AD (Abstract)

Lagler

Exploring novel executive functioning tasks for high-frequency testing using within- and across-task sensitivity (Abstract)

McCoy

Speaker verification for remote self-assessments in clinical trials (Abstract)

Meepegama

Correlation between the Personal and Social Performance scale (PSP) and the Positive and Negative Syndrome Scale (PANSS) in an individual countries sample (Abstract)

Micaletto

Poor performance on diagnostic tests in early dementia clinical trials as a marker of possible score inflation. An exploratory analysis (Abstract)

Miller

Typing speed as a digital biomarker for processing speed among Hispanics Latinos (Abstract)

Moore

Towards an interpretable index score for the assessment of schizophrenia based on multimodal speech and facial biomarkers (Abstract)

Neumann

How do threshold MADRS eligibility criteria influence MADRS scoring? (Abstract)

Roy

Characterization of success rates and placebo response in clinical trials of pharmacotherapies for generalized anxiety disorder (Abstract)

Schafer

Utilizing experienced research networks to conduct global clinical trials in difficult to access populations (Abstract)

Simmons

Automated extraction of fatigue content from voice diary data (Abstract)

Taptiklis

Ecological momentary analysis of high-frequency cognitive testing and its relationship to fatigue and sleep (Abstract)

Veldsman

High compliance to remote high-frequency cognitive testing across immune mediated inflammatory disease and neurodegenerative disease patients (Abstract)

Veldsman

Assessing reliability and sensitivity of the Psychomotor Vigilance Task in a long-term longitudinal study of sleep EEG: the impact of task length on sleep-related measures (Abstract)

Viola

Automated scoring of logical memory test directly from audio recordings: Enhancing test reliability and reducing measurement noise (Abstract)

Weston

Evaluating cognitive composite measures for power to detect treatment differences (Abstract)

Wragg